[5-methoxy-2-methyl-1-(4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)-1H-indol-3-yl]acetic acid | 502605-85-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: [5-methoxy-2-methyl-1-(4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)-1H-indol-3-yl]acetic acid
• 英文别名: 2-(1-(4-((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ylmethoxy)benzoy)-2-methyl-5-methoxyindol-3-yl)acetic acid；2-(1-(4-((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ylmethoxy)benzoyl)-2-methyl-5-methoxyindol-3-yl)acetic acid；2-[5-methoxy-2-methyl-1-[4-[[(2S)-4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl]methoxy]benzoyl]indol-3-yl]acetic acid
• CAS: 502605-85-8
• 化学式: C₂₉H₂₈N₂O₆
• 分子量: 500.551
• InChiKey: WMUFBYGHMKJROO-QFIPXVFZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  37
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  90.2
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  [(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methyl 4-methylbenzenesulfonate 在 草酰氯 、 20% palladium hydroxide on carbon 、 四丁基氯化铵 、 氢气 、 potassium carbonate 、 N,N-二甲基甲酰胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 二氯甲烷 、 水 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 16.33h， 生成 [5-methoxy-2-methyl-1-(4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)-1H-indol-3-yl]acetic acid
  参考文献：
  名称：

  Discovery of selective indole-based prostaglandin D2 receptor antagonist

  摘要：

  A series of N-benzoyl-2-methylindole-3-acetic acids were synthesized and biologically evaluated as prostaglandin (PG) D-2 receptor antagonists. Some of the selected compounds significantly inhibited OVA-induced vascular permeability in guinea pig conjunctiva after oral dosing. Structure-activity relationship study is presented. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.06.014

文献信息

• Indole derivatives
  申请人：Torisu Kazuhiko

  公开号：US20050004097A1

  公开（公告）日：2005-01-06

  Compounds represented by formula (I) wherein all symbols represent the same meanings as described in specification. and salts thereof. Since the compound represented by the formula (I) binds and antagonizes to DP receptor, it is useful for the prevention or treatment against the disease such as allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease, and ulcerative colitis.

  化学式为（I）的化合物及其盐，其中所有符号的含义如规范中所述。由于化学式（I）所代表的化合物能够结合和拮抗DP受体，因此它对于预防或治疗过敏性疾病、伴随瘙痒的疾病、由于瘙痒引起的行为所导致的继发性疾病、炎症、慢性阻塞性肺疾病、缺血再灌注障碍、风湿性关节炎并发的胸膜炎、脑血管疾病和溃疡性结肠炎等疾病具有用处。
• INDOLE DERIVATIVES
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1424335A1

  公开（公告）日：2004-06-02

  Compounds represented by formula (I) wherein all symbols represent the same meanings as described in specification. and salts thereof. Since the compound represented by the formula (I) binds and antagonizes to DP receptor, it is useful for the prevention or treatment against the disease such as allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease, and ulcerative colitis.

  式 (I) 所代表的化合物 及其盐类。 由于式（I）代表的化合物能与 DP 受体结合并产生拮抗作用，因此可用于预防或治疗过敏性疾病、伴随瘙痒的疾病、由瘙痒引起的行为导致的继发性疾病、炎症、慢性阻塞性肺病、缺血性再灌注疾病、类风湿性关节炎并发的胸膜炎、脑血管疾病和溃疡性结肠炎等疾病。
• US7135495B2
  申请人：——

  公开号：US7135495B2

  公开（公告）日：2006-11-14
• US7291644B2
  申请人：——

  公开号：US7291644B2

  公开（公告）日：2007-11-06